Leonne Prompers, Medical manager, nuclear medicine Physician bij Zuyderland: EANM Brochure - Principles and Practice of PET/CT, Part 2 A Technologist's Guide with 41 contributing authors. Principles of PET radiochemistry. Clinical applications of PET/CT in oncology. Clinical applications of PET/CT in infection and inflammation. Clinical applications of PET/CT in cardiology. Clinical applications of PET/CT in neurology.
The Y nutrition guide: Following these diet recommendations, plus being physically active and maintaining a healthy weight, can go far in helping prevent cancer. For a simpler rule of thumb, you can also follow the advice of Michael Pollan, author of In Defense of Food: An Eater's Manifesto: "Eat food. Not too much. Mostly plants." According to the American Cancer Society, almost 1.7 million new cancer cases and more than 600,000 cancer-related deaths are projected to occur in the United States this year, 2017.
European Association of Nuclear Medicine: Prostate cancer patients who are resistant to hormone treatment used to have a poor prognosis. Until recently, the diagnostic and therapeutic possibilities had been limited, but now innovative developments in nuclear medicine imaging and therapy open up promising pathways. Novel substances used with PET/CT (positron-emission tomography combined with computed tomography) not only allow for better diagnosis but also offer treatment options where other therapies have failed.
European Association of Nuclear Medicine: For tumor patients the timely choice of the appropriate therapy is of vital importance.Nuclear medical methods such as PET (positron emission tomography) allow not only for targeting the tumor but also for assessing the treatment outcome soon after therapy onset. This enables doctors to change treatment if necessary and adapt it to the specific conditions and needs of their patients. A non-responder patient can be identified very soon after therapy onset so that non-effective chemotherapy can be immediately stopped, reducing adverse side effects through inefficient toxicity and enabling an early salvage approach, for example by shifting to a different drug or to radiotherapy.